National Task Force, JMG will decide whether to continue plasma therapy for COVID treatment: ICMR
National Task Force, JMG will decide whether to continue plasma therapy for COVID treatment: ICMR
newKerala.com
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
NA Proactive news snapshot: Nemaura Medical, The Valens Company, Revive Therapeutics, KWESST, Victory Resources UPDATE …
Proactive Investors
-
NA Proactive news snapshot: WeedMD, Thoughtful Brands, Gevo, Biocept, TRACON Pharmaceuticals, Newrange Gold, BioSig Technologies, Naturally Splendid Enterprises UPDATE ...
Proactive Investors
-
Maharashtra's plan to 'ration' oxygen attracts flak from doctors
Mid-Day
-
People letting their guard down is worrying: Experts on COVID-19
Mid-Day
Advertisement
More coverage
What World After The Pandemic? – Analysis
Eurasia Review
The unpredictable crisis of Covid-19 raises fundamental questions at several levels. It questions the current form of..
-
Delhi hospital highlights higher COVID-19 fatality rate in cancer patients
Mid-Day
-
Coronavirus outbreak: 35 armed forces men lost battle against COVID-19
Mid-Day
-
National Task Force, JMG will decide on continuing plasma therapy for treatment of Covid patients: ICMR
IndiaTimes
-
No shortage of medical oxygen for COVID-19 patients: Health Ministry
Mid-Day